Tinidazole for bacterial vaginosis

References

• Sobel JD. Vaginitis. N. Engl. J. Med.337(26), 1896–1903 (1997).
   PubMed Web of Science ®Google Scholar
• Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N. Engl. J. Med.353, 1899–1911 (2005).
   PubMed Web of Science ®Google Scholar
• Ferris MJ, Masztal A, Aldridge KE, Fortenberry JD, Fidel PL Jr, Martin DH. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect. Dis.13(4), 5 (2004).
   Google Scholar
• Amsel R, Totten PA, Spegel CA et al. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am. J. Med.74, 14–22 (1983).
   PubMed Web of Science ®Google Scholar
• Morbidity and Mortality Weekly Report. Sexually transmitted diseases treatment guidelines. MMWR Morb. Mortal. Wkly Rep.55, RR-11 (2006).
   Google Scholar
• Fung HB, Doan T. Tinidazole: a nitroimidazole antiprotozoal agent. Clin. Ther.27(12), 1859–1884 (2005).
   PubMed Web of Science ®Google Scholar
• Nord CE, Kager L. Tinidazole – microbiology, pharmacology and efficacy in anaerobic infections. Infection11(1), 54–60 (1983).
   PubMed Web of Science ®Google Scholar
• Lamp KC, Freeman CD, Klutman NE, Lacy MK. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials. Clin. Pharmacokinet.36(5), 353–373 (1999).
   PubMed Web of Science ®Google Scholar
• Mattila J, Mannisto PT, Mantyla R, Nykanen S, Lamminsivu U. Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route. Antimicrob. Agents Chemother.23(5), 721–725 (1983).
   PubMed Web of Science ®Google Scholar
• Mannisto P, Karhunen M, Mattila J et al. Concentrations of metronidazole and tinidazole in female reproductive organs after a single intravenous infusion and after repeated oral administration. Infection12, 197–201 (1984).
   PubMed Web of Science ®Google Scholar
• Carmona O, Silva H, Acosta H. Vaginitis due to Gardnerella vaginalis: treatment with tinidazole. Curr. Ther. Res.22, 898–904 (1983).
   Google Scholar
• Mohanty KC, Deighton R. Comparison of 2 g single dose of metronidazole, nimorazole and tinidazole in the treatment of vaginitis associated with Gardnerella vaginalis. J. Antimicrob. Chemother.19, 393–399 (1987).
   PubMed Web of Science ®Google Scholar
• Austin MN, Meyn LA, Hillier SL. Susceptibility of vaginal bacteria to metronidazole and tinidazole. Anaerobe12(5–6), 227–230 (2006).
   PubMed Web of Science ®Google Scholar
• Milani M, Barcellona E, Agnello A. Efficacy of the combination of 2 g oral tinidazole and acidic buffering vaginal gel in comparison with vaginal clindamycin alone in bacterial vaginosis: a randomized, investigator-blinded, controlled trial. Eur. J. Obstet. Gynecol. Reprod. Biol.109, 67–71 (2003).
   PubMed Web of Science ®Google Scholar
• Buranawarodomkul P, Chandeying V, Sutthijumroon S. Seven day metronidazole versus single dose tinidazole as therapy for nonspecific vaginitis. J. Med. Assoc. Thai.73, 283–287 (1990).
   PubMedGoogle Scholar
• Sanz-Sanz F, Hernanz AD, Sancher EA, Alvarez CG, Muelas M, Rodriguez-Noriega A. Controlled comparative study of metronidazole (Flagyl) versus tinidazole (Tricolan) in the treatment of nonspecific vaginitis (vaginitis due to Gardnerella vaginalis). Rev. Gynecol. Obstet.44, 717–720 (1985).
   Google Scholar
• Schindler EM, Thamm H, Ansmann EB, Sarnow E, Schindler AE. Treatment of bacterial vaginitis. Multicenter, randomized, open study with tinidazole in comparison with metronidazole. Fortschr. Med.109(5), 138–140 (1991).
   PubMedGoogle Scholar
• Sanz-Sanz F, Arreaza L, Vidriales I, Miranda P, Grande J, Valle R. Concerning the different therapeutic options for bacterial vaginosis. Progresos Obstet. Ginecol.39, 669–674 (1996).
   Web of Science ®Google Scholar
• Milani M, Baldoni A, Guerro B, Spinillo A. The “talent” multicenter trial: efficacy of tinidazole, metronidazole, and tinidazole + acidic vaginal gel in the treatment of B. vaginosis. Abstracts of the 86th World Congress for Infectious and Immunological Diseases in Obstetrics and Gynecology. Venice, Italy, November (2003).
   Google Scholar
• Ekgren J, Norling BK, Degre M, Midtvedt T. Comparison of tinidazole given as a single dose and on 2 consecutive days for the treatment of nonspecific bacterial vaginosis. Gynecol. Obstet. Invest.26, 313–317 (1988).
   PubMed Web of Science ®Google Scholar
• Paavonen J, Vesterinen E, Purola E et al. Single dose of tinidazole in the treatment of vaginal discharge. Scand. J. Urol. Nephrol. Suppl.86, 237–240 (1984).
   PubMedGoogle Scholar
• van der Meijden WI. Treatment of non-specific vaginitis with a single dose of tinidazole. Scand. J. Infect. Dis. Suppl.40, 85–89 (1983).
   PubMedGoogle Scholar
• Bagnoli VR, Kesselring GL. Multicenter, double-blind, randomized, comparative study between secnidazole (single dose of 2g) and tinidazole (single dose of 2g) in the treatment of nonspecific vagiitis. RBM Ginecologia E Obstetricia3, 198–202 (1992).
   Google Scholar
• Vutyavanich T, Pongsuthirak P, Vannareumol P, Ruangsri RA, Luangsook P. A randomized double-blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstet. Gynecol.82, 550–554 (1993).
   PubMed Web of Science ®Google Scholar
• Bardi M, Manenti G, Mattioni D, Lasala L. Activity of some metronidazole analogs on vaginitis caused by Haemophilus vaginalis: comparative clinical study. Gior. It. Ost. Gin.4, 503–506 (1982).
   Google Scholar
• Martins N. Ambulatory diagnosis of vaginitis: evaluation of 4903 patients treated with tinidazole with a single oral dose. Rev. Bras. Clin. Terap.14, 94–98 (1985).
   Google Scholar
• Improda L, Nobler L, Chierego C, Iacono A, Sica C, Rullo F. Is it necessary to treat the partner of a woman affected by bacterial vaginosis? Gior. It. Ost. Gin.7–8, 371–373 (1994).
   Google Scholar
• Villagrana-Zesati R, Reyna-Figueroa J, Ortiz-Ibarra J. Short-term therapy for mixed vaginal infections. Int. J. Gynaecol. Obstet.92, 149–150 (2006).
   PubMed Web of Science ®Google Scholar
• Bardi M, Manenti G, Mattioni D, Lasala L. Activity of some metronidazole analogs on vaginitis caused by Haemophilus vaginalis: comparative clinical study. Gior. It. Ost. Gin.4, 503–506 (1982).
   Google Scholar
• de la Cabada FJ. Treatment of vaginitis due to Gardnerella vaginalis with tinidazole. Invest. Med. Int.15, 66–71 (1988).
   Google Scholar
• Sanz-Sanz F, Del Palacio Hernanz A, Sanchez E et al. Double-blind randomized comparative trial: ornidazole (Tiberal®) versus tinidazole (Falsigin®) for the treatment of non-specific vaginitis. Chemioterapla4(3), 218–221 (1998).
   Google Scholar
• Piot P, Van Dyck E, Godts P, Vanderheyden J. A placebo-controlled, double-blind comparison of tinidazole and triple sulfonamide cream for the treatment of nonspecific vaginitis. Am. J. Obstet. Gynecol.147, 85–89 (1983).
   PubMed Web of Science ®Google Scholar
• Heikkinen J, Vuopala S. Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecol. Obstet. Invest.28, 98–100 (1989).
   PubMed Web of Science ®Google Scholar
• Baylson FA, Nyirjesy P, Weitz MV. Treatment of recurrent bacterial vaginosis with tinidazole. Obstet. Gynecol.104, 931–932 (2004).
   PubMed Web of Science ®Google Scholar
• Schwebke JR, Provan A, Barrientes F. Treatment of resistant Trichomonas vaginalis and bacterial vaginosis with tinidazole. Abstract 0021 of the International Society of Sexually Transmitted Diseases Research 15th Biennial Congress. Ontario, Canada, July (2003).
   Google Scholar
• Package insert. Tindamax®, Presutti Laboratories, IL, USA.
   Google Scholar